Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer chemotherapy can cause permanent hair loss.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Inactive hair follicle stem cells help prevent skin cancer.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Some birth control pills have a higher risk of blood clots than others.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

SHBG may be a useful early indicator and treatment target for PCOS.

Different methods of preparing Platelet-Rich Plasma (PRP) can affect wound healing and hair regrowth in plastic surgery. Using a kit with specific standards helps isolate PRP that meets quality criteria. Non-Activated PRP and Activated PRP have varying effects depending on the tissue and condition treated. For hair regrowth, Non-Activated PRP increased hair density more than Activated PRP. Both treatments improved various aspects of scalp health.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Products should be called 'sperm-safe' only after thorough, well-designed tests.